Evidence map›Paper›PMID 31950242›Full record

ArticleVirchows Archiv : an international journal of pathology2020

Clinicopathologic analysis of upper urinary tract carcinoma with variant histology.

Inês Rolim, Vanessa Henriques, Nídia Rolim, Ana Blanca, Rita Canas Marques, Metka Volavšek, Inês Carvalho, Rodolfo Montironi, Alessia Cimadamore, Maria R Raspollini and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. [Correlation between daily fluid intake behavioral habits and pathological characteristics of upper tract urothelial carcinoma].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Microcystic urothelial carcinoma: a case report.International journal of clinical and experimental pathology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Inês RolimServiço de Anatomia Patológica, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E, Lisbon, Portugal.
Vanessa HenriquesAnatomic Pathology Service, Champalimaud Clinical Center, Lisbon, Portugal.ORCID https://orcid.org/0000-0002-2154-0853
Nídia RolimServiço de Urologia, Hospital de Egas Moniz, Lisbon, Portugal.
Ana BlancaMaimonides Biomedical Research Institute of Cordoba, Cordoba, Spain.
Rita Canas MarquesAnatomic Pathology Service, Champalimaud Clinical Center, Lisbon, Portugal.
Metka VolavšekInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Inês CarvalhoAnatomic Pathology Service, Champalimaud Clinical Center, Lisbon, Portugal.
Rodolfo MontironiInstitute of Pathological Anatomy and Histopathology, Ancona, Italy.
Alessia CimadamoreInstitute of Pathological Anatomy and Histopathology, Ancona, Italy.ORCID https://orcid.org/0000-0001-5981-3514
Maria R RaspolliniHistopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy.
Liang ChengDepartments of Pathology and Laboratory Medicine and Urology, Indiana University, Indianapolis, IN, USA.
Antonio Lopez-BeltranDepartment of Surgery and Pathology, Faculty of Medicine, Cordoba University, Cordoba, Spain. em1lobea@uco.es.ORCID https://orcid.org/0000-0003-3161-8164
Champalimaud Foundation · PTAzienda Ospedaliero-Universitaria Careggi · ITHospital de Egas Moniz · PTIndiana University – Purdue University Indianapolis · USInstituto Maimónides de Investigación Biomédica de Córdoba · ESUniversity of Ljubljana · SI

Funding

Ministerio de Salud y Protección Social PI17/01981
6 · The paper itself

Abstract

We report on the clinicopathologic features of 115 cases of high-grade urothelial carcinoma of the upper urinary tract with variant histology present in 39 (34%). Variant histology was typically seen in high pathological stage (pT2-pT4) (82%, 32 cases) patients with lower survival rate (70%, 27 cases, median survival 31 months) and consisted in urothelial with one (23%), two (3%), and three or more variants (3%); 4% of cases presented with pure variant histology. Squamous divergent differentiation was the most common variant (7%) followed by sarcomatoid (6%) and glandular (4%), followed by 3% each of micropapillary, diffuse-plasmacytoid, inverted growth, clear cell glycogenic, or lipid-rich. The pseudo-angiosarcomatous variant is seen in 2%, and 1% each of nested, giant-cell, lymphoepithelioma-like, small-cell, trophoblastic, rhabdoid, microcystic, lymphoid-rich stroma, or myxoid stroma/chordoid completed the study series. Loss of mismatch repair protein expression was identified in one case of upper urinary tract carcinoma with inverted growth variant (3.6%). Variant histology was associated to pathological stage (p = 0.007) and survival status (p = 0.039). The univariate survival analysis identified variant histology as a feature of lower recurrence-free survival (p = 0.046). Our findings suggest that variant histology is a feature of aggressiveness in urothelial carcinoma of the upper urinary tract worth it to be reported.

Indexed as

AgedAged, 80 and overCarcinoma, Squamous CellCarcinoma, Transitional CellFemaleHumansMaleMiddle AgedUrinary Bladder NeoplasmsUrinary TractUrologic NeoplasmsUrotheliumDivergentGlandularMicropapillaryMMRNestedPlasmacytoidRenal pelvisSarcomatoidSquamousUreterUrothelial carcinomaVariant histology

Identifiers

PMID31950242
OpenAlexW2999928687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.